Genetic Scientists Put Down's Syndrome on the Map
May 8, 2000 -- With their new genetic inventory of chromosome 21, scientists may have taken another big step toward understanding and treating genetic diseases. And with a map of this chromosome, the second such genetic compilation assembled since chromosome 22 was mapped last year, fellow investigators say they now have a solid foundation for their own studies.
"For Down's syndrome researchers, this is really a major milestone," physiologist Roger Reeves, PhD, tells WebMD. "So now we have a complete ... catalogue of the genes on chromosome 21. And we know that one or a few or all of these are the primary contributors to Down's syndrome." Reeves, a Down's syndrome investigator and professor of physiology at Johns Hopkins University in Baltimore, wrote an accompanying paper to the chromosome 21 report that will be released in Thursday's issue of the journal Nature.
Down's syndrome, the most common form of genetically caused mental retardation, occurs when a person is born with an extra, third copy of chromosome 21. It occurs in about one in 700 live births and can also cause congenital heart disease and Alzheimer's by age 40.
"For the first time," Reeves says, "we can define the playing field and who the players are on that field, and that's very, very important in allowing us to focus efforts in Down's syndrome."
The map may allow researchers to home in on specific genes in the chromosome that cause mental retardation in people with Down's syndrome and then perhaps develop drugs to treat such patients.
"Once we can find the genes that are important for learning problems, what we hope is that we'll be able to understand what those genes do and somehow compensate for having an extra copy of the gene," says David Patterson, PhD, president of the Eleanor Roosevelt Institute in Denver and chairman of the science advisory board of the National Down's Syndrome Society.
"Another volume has just been placed on the shelf. Now we really have to roll up our sleeves and assess what these genes are doing there, what role they play in causing disease," says Francis Collins, MD, PhD, chairman of the Human Genome Project at the National Institutes of Health in Bethesda, Md. Patterson is involved in the project as well.